Obesity Studies

Cel-CS1K: A Celastrol-Chitosan Conjugate for Treating Diet-Induced Obesity.

Celastrol-chitosan conjugate Cel-CS1K showed promise as an antiobesity drug with higher drug loading, good solubility, and reduced toxicity compared to free Cel. It effectively reduced body weight, improved metabolic markers, and regulated adipose-related genes in obese mice, offering a potential therapeutic strategy for obese humans.

Zeng H et al (2024).
Chem Res Toxicol.
PubMed:
38771988

The therapeutic effects of traditional Chinese medicine on insulin resistance in obese mice by modulating intestinal functions.

TCM herbal formula targets visceral fat, hormone imbalance, and inflammation to combat obesity. Promising alternative to conventional treatments with potential for radical effects and fewer side effects.

Ma L et al (2024).
Heliyon.
PubMed:
38765147

Baicalin suppresses macrophage JNK-mediated adipose tissue inflammation to mitigate insulin resistance in obesity.

Researchers studied how baicalin, a compound in Radix scutellariae, can help reduce inflammation in metabolic disorders like obesity. Baicalin can potentially improve insulin resistance in obesity by modulating macrophages.

Zhu Z et al (2024).
J Ethnopharmacol.
PubMed:
38762213

SIRT1/AMPK-mediated pathway: Ferulic acid from sugar beet pulp mitigating obesity-induced diabetes-linked complications and improving metabolic health.

Sugar beet pulp extract (SBP-E) from ferulic acid reduces oxidative stress, improves glucose and lipid metabolism, and decreases inflammation in obesity-induced type 2 diabetes. SBP-E activates SIRT1/AMPK signaling and modulates the AMPK/SREBP1/ACC1 pathway, offering potential treatment benefits.

Singh SSB and Patil KN (2024).
Biochim Biophys Acta Mol Cell Biol Lipids.
PubMed:
38761896

Cichorium glandulosum Ameliorates HFD-Induced Obesity in Mice by Modulating Gut Microbiota and Bile Acids.

Chicory extract (CG) delayed weight gain, improved metabolism, reduced oxidative stress, and balanced gut microbiota in obese mice. CG may be beneficial for treating obesity and metabolic issues by targeting the gut microbiome and bile acid production.

Zhong Y et al (2024).
J Med Food.
PubMed:
38742981

The synchronized feature of Saururus chinensis and gut microbiota against T2DM, NAFLD, obesity and hypertension via integrated pharmacology.

Study uncovers therapeutic potential of gut microbiota and plant compounds for metabolic disorders. Key genes and bioactive compounds identified could lead to novel treatments for type 2 diabetes, NAFLD, obesity, and hypertension.

Oh KK et al (2024).
Artif Cells Nanomed Biotechnol.
PubMed:
38733373

Usefulness of Opuntia spp. on the Management of Obesity and Its Metabolic Co-Morbidities.

Researchers examined the potential of nopal cactus extracts for treating metabolic disorders like obesity. While promising in preclinical studies, more research is needed to understand their mechanisms and effectiveness in clinical settings.

Gómez-García I et al (2024).
Nutrients.
PubMed:
38732528

The protective effects of some herbs on mitigating HFD-induced obesity via enhancing biochemical indicators and fertility in female rats.

Study showed that diets enriched with fennel and coriander reduced obesity risks and improved fertility in obese female rats better than chia seeds and hibiscus. Consider plant-based diets for obesity prevention.

Abdoon ASS et al (2024).
Heliyon.
PubMed:
38726161